[direct reporting network on December 1 hearing] (Department of Commerce) today, the Ministry of Commerce direct selling industry management information system display, Liaoning future biological won the 70 license, but also in Liaoning Province Ji Baoli (China), and the Dalian ShuangDi after the third licence. July 28, 2014, the Ministry of Commerce announced the future of Liaoning biotechnology applications direct statement. This is just a response to the news has been announced to obtain direct sales license.

Liaoning future Biotechnology Co., Ltd.

Liaoning future Bio Technology Co., Ltd. is a Liaoning province Biomedical Engineering Research Institute of holding company, is a commitment to human health industry of high-tech biotechnology companies, mainly engaged in biological products (health food, food, bio pharmaceutical) research and development, production and sales. Biotech Inc. Future is a wholly owned subsidiary of the company in the United states.

At the beginning of 2010 settled in Liaoning Province of China drugs (National Bio pharmaceutical science and technology industrial base) and 8045 million yuan registered capital, covers an area of 170 mu, with a total investment of 2.1 billion yuan, is one of the domestic largest antioxidant enzyme production base.

The company has excellent biological and technical personnel, advanced technology and equipment, as well as a strong economic strength. Independent research and development production of Yuan Connaught capsules by the world's first closed-end biological extraction technology (patent), for the main components developed from extracted from corn germ of three antioxidant enzymes, has been the Chinese Drug Administration approval and obtain FDA food and drug supervision and Management Bureau registered symbol. 3

Editor: small Shen

Interpretation of the hot news, showing sensitive events, more exclusive analysis, in the direct thing, micro channel, scan two-dimensional code free reading.